🟢 NeOnc Technologies Holdings is trading 5% up today as biotech stocks outperform

NeOnc Technologies Holdings is trading at $4.98, up +5.29% during the September 2, 2026 session, primarily as biotech stocks outperform.

• No September 2 company-specific announcement or material filing has been identified; the latest major update was positive NEO100 Phase 2a data released August 12.
• Biotech stocks are outperforming, with XBI up 2.75%, helped by Purple Biotech’s patent news and broader positive clinical-data momentum.
• The move appears primarily sector-driven, rather than caused by fresh NeOnc news.